Development Level

Tbio 8 | 11,445
Tclin 1 | 613

IMPC Phenotype

abnormal behavior 1 | 298
abnormal femur morphology 1 | 14
preweaning lethality, incomple... 1 | 499

Disease

Carcinoma 9 | 11,493
Kidney cancer 7 | 2,613
ependymoma 6 | 4,679
ovarian cancer 6 | 8,520
Astrocytoma, Pilocytic 5 | 3,081
adult high grade glioma 5 | 3,801
glioblastoma 5 | 5,792
lung cancer 5 | 4,740
oligodendroglioma 5 | 2,850
Breast cancer 4 | 3,578
Cancer 4 | 2,499
breast carcinoma 4 | 1,638
group 4 medulloblastoma 4 | 1,855
lung carcinoma 4 | 2,843
non-small cell lung cancer 4 | 2,890
osteosarcoma 4 | 7,950
psoriasis 4 | 6,694
Atopic dermatitis 3 | 952
Autistic Disorder 3 | 364
Vesicoureteral reflux 3 | 32
astrocytic glioma 3 | 2,597
atypical teratoid / rhabdoid tumor 3 | 5,112
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
invasive ductal carcinoma 3 | 2,951
lung adenocarcinoma 3 | 2,716
malignant mesothelioma 3 | 3,232
pituitary cancer 3 | 1,972
Congenital diaphragmatic hernia 2 | 67
Heart disease 2 | 306
Liver cancer 2 | 604
Melanoma 2 | 711
Pick disease 2 | 1,894
Schizophrenia 2 | 1,160
Skin cancer 2 | 469
Vascular disease 2 | 319
colon cancer 2 | 1,478
cystic fibrosis 2 | 1,696
ductal carcinoma in situ 2 | 1,745
fibroadenoma 2 | 559
head and neck cancer 2 | 271
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
medulloblastoma, large-cell 2 | 6,241
pancreatic cancer 2 | 2,398
primary pancreatic ductal adenocarcinoma 2 | 1,109
primitive neuroectodermal tumor 2 | 3,035
sarcoidosis 2 | 370
Adenocarcinoma 1 | 122
Agammaglobulinemia 1 | 34
Amblyopia 1 | 38
Anorexia nervosa 1 | 80
Arthritis 1 | 290
Bladder Neoplasm 1 | 112
Breast Neoplasms 1 | 445
COPD 1 | 118
Carcinoma of colon 1 | 32
Carcinoma, Hepatocellular 1 | 228
Cardiomegaly 1 | 116
Cardiovascular system disease 1 | 246
Cholangiocarcinoma 1 | 35
Colitis 1 | 54
Colonic Neoplasms 1 | 142
Colorectal Neoplasms 1 | 243
Common variable immunodeficiency 1 | 101
Hyperopia 1 | 70
Impotence 1 | 42
Kidney disease 1 | 430
Liver Cirrhosis, Experimental 1 | 769
Liver carcinoma 1 | 240
Lung Neoplasms 1 | 232
Major Depressive Disorder 1 | 301
Mammary Neoplasms 1 | 425
Neoplasm Invasiveness 1 | 161
Neuropathy 1 | 261
Orofacial cleft 1 | 54
Osteopetrosis 1 | 43
Osteoporosis 1 | 363
Renal Cell Carcinoma 1 | 214
Renal agenesis 1 | 29
Status Epilepticus 1 | 98
Stomach Neoplasms 1 | 300
Type 2 diabetes mellitus 1 | 272
Unipolar Depression 1 | 250
Urinary Bladder Neoplasms 1 | 114
Urinary bladder cancer 1 | 36
active Crohn's disease 1 | 922
adrenocortical carcinoma 1 | 1,428
atypical teratoid/rhabdoid tumor 1 | 357
facioscapulohumeral dystrophy 1 | 288
glioblastoma multiforme 1 | 142
interstitial lung disease 1 | 298
nasopharyngeal carcinoma 1 | 1,058
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,962
posterior fossa group A ependymoma 1 | 468
severe Alzheimer's disease 1 | 47
sonic hedgehog group medulloblastoma 1 | 467
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 2,010

Tissue

Blood and immune system 9 | 16,909
Digestive Tract 9 | 17,369
Endocrine System 9 | 18,159
Female tissues 9 | 17,400
Male tissues 9 | 17,142
Nervous System 9 | 16,725
Respiratory system 9 | 16,393
Skin and soft tissues 9 | 17,230
Liver and Pancreas 8 | 16,750
Cardiovascular System 7 | 15,192
Urinary Tract 7 | 16,678

Target Family

Non-IDG 7 | 12,091
Enzyme 1 | 4,145
Kinase 1 | 634

Reactome Pathway

Regulation of commissural axon... 9 | 9
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Roundabout homolog 2 ROBO2 Tbio Non-IDG -1.89275 74.1 161
Roundabout homolog 3 ROBO3 Tbio Non-IDG -1.96617 89.3 140
Roundabout homolog 1 ROBO1 Tbio Non-IDG -2.15518 129.8 261
Slit homolog 2 protein SLIT2 Tbio Non-IDG -2.01765 104.0 215
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -4.00292 9201.7 1455
Slit homolog 3 protein SLIT3 Tbio Non-IDG -2.18325 163.8 142
Slit homolog 1 protein SLIT1 Tbio Non-IDG -1.71027 44.8 121
Protein kinase C-binding protein NELL2 NELL2 Tbio Enzyme -1.21901 24.1 110
Netrin-1 NTN1 Tbio Non-IDG -2.66852 504.7 244